ArticleCell biochemistry and biophysics2026
Molecular Docking and Simulation of Bioactive Molecules from Antiepileptic Plant Extract Presenting Significant Result in in-vivo Study.
Article in Cell biochemistry and biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Moringa oleifera (Lam), Bacopa monnieri (Lam), and Ipomoea aquatica (Forssk) have long been utilized in traditional medicine for their antiepileptic properties. This study investigates the efficacy of these plant extracts in mitigating seizures and associated physiological alterations, aiming to identify potential bioactive compounds through combined in vivo and in silico approaches. Behavioral assessments revealed that seizures significantly impair spatial memory and neuromuscular coordination. Hormonal profiling indicated notable disruptions in reproductive hormones—luteinizing hormone (LH), follicle-stimulating hormone (FSH), and prolactin—while thyroid-stimulating hormone (TSH) remained unaffected. Among the tested extracts, M. oleifera leaf extract exhibited the most pronounced therapeutic effect, demonstrating significant reversal of seizure-induced behavioral and hormonal abnormalities. Phytochemical screening and molecular docking of selected eleven terpenoid compounds in M. oleifera extract were evaluated for their binding affinity to Gamma-Aminobutyric Acid (GABA) transaminase, a key enzyme implicated in seizure pathology. Subsequent in silico stability analyses highlighted three compounds; Farnesylacetone, 6,10,14-Trimethylpentadecan-2-one, and Citronellyl Valerate—as promising candidates, showing higher binding affinity and stability in Molecular Dynamics Simulation and MMGBSA analysis compared to established antiepileptic drugs. These findings suggest that M. oleifera leaf extract, particularly its terpenoid constituents, holds significant potential for the development of novel antiepileptic therapeutics targeting GABA metabolism.
Indexed as
Identifiers
41045351What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.